Discriminators between Hantavirus-Infected and -Uninfected Persons Enrolled in a Trial of Intravenous Ribavirin for Presumptive Hantavirus Pulmonary Syndrome
Open Access
- 1 February 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 34 (3) , 293-304
- https://doi.org/10.1086/324619
Abstract
To provide a potentially therapeutic intervention and to collect clinical and laboratory data during an outbreak of hantavirus pulmonary syndrome (HPKeywords
This publication has 7 references indexed in Scilit:
- Rapid Presumptive Diagnosis of Hantavirus Cardiopulmonary Syndrome by Peripheral Blood Smear ReviewAmerican Journal of Clinical Pathology, 2001
- Intravenous Ribavirin for Hantavirus Pulmonary Syndrome: Safety and Tolerance during 1 Year of Open-Label ExperienceAntiviral Therapy, 1999
- Hantavirus Pulmonary Syndrome, Renal Insufficiency, and Myositis Associated with Infection by Bayou HantavirusClinical Infectious Diseases, 1996
- Cardiopulmonary manifestations of hantavirus pulmonary syndromeCritical Care Medicine, 1996
- Hantavirus pulmonary syndrome in Florida: Association with the newly identified Black Creek Canal virusThe American Journal of Medicine, 1996
- Clinical Features That Differentiate Hantavirus Pulmonary Syndrome from Three Other Acute Respiratory IllnessesClinical Infectious Diseases, 1995
- Hantavirus Pulmonary Syndrome: A Clinical Description of 17 Patients with a Newly Recognized DiseaseNew England Journal of Medicine, 1994